A1W48J Serstech AB

Third quarter report 2023

Third quarter report 2023

SERSTECH GROUP, 1 JULY – 30 SEPTEMBER 2023

  • Net sales amounted to KSEK 13 593 (3 125), an increase of 335%.
  • EBITDA amounted to KSEK -329 (-2 957), corresponding to an EBITDA margin of -2%.
  • EBIT amounted to KSEK -3 333 (-4 637), corresponding to an EBIT margin of -25%.
  • Cash flow from operating activities amounted to KSEK 12 719 (1 574).
  • Earnings per share amounted to SEK -0.02 (-0.06).
  • Earnings per average number of shares amounted to SEK -0.02 (-0.06).

SERSTECH GROUP, 1 JANUARY – 30 SEPTEMBER 2023

  • Net sales amounted to KSEK 58 704 (13 624), an increase of 331%.
  • EBITDA amounted to KSEK 17 146 (-8 061), corresponding to an EBITDA margin of 29%.
  • EBIT amounted to KSEK 8 215 (-13 099), corresponding to an EBIT margin of 14%.
  • Cash flow from operating activities amounted to KSEK 2 964 (-11 767).
  • Earnings per share amounted to SEK 0.04 (-0.16).
  • Earnings per average number of shares amounted to SEK 0.05 (-0.16).

Comments from the CEO

Net sales grew by 335% in the third quarter and the operational cashflow was positive by 2.9 MSEK for the nine-month period. Given the high EBITDA result from the first nine months, we expect that we will be EBITDA positive for the full year 2023, for the first time ever. The strong sales are driven by both the war in Ukraine and the increasing demand for narcotics identification within law enforcement. We expect the high demand to remain for at least the next few years.

Most of our sales so far this year have come from three large orders, but we also see a strong increase in the run-rate business, i.e. the many small orders that we receive from our partners without our direct involvement. The high number of smaller orders are both proof that our partner network is performing well and that the demand is not limited to a few geographical markets. As our partner network evolves and becomes more capable, our direct involvement in each business opportunity decreases, allowing our sales team to focus on the larger opportunities and business development.

The two orders we received from our partner Kaiser in Singapore were significant not only for their size. The July order was the first time we receive a second larger order from the same end-customer, who has indicated that we should continue to expect repeat orders over the coming years. The end-user is within narcotics law enforcement, which remains our largest customer segment and for which our Serstech Arx and Serstech ChemDash are perfectly suited.

For more than a year, our R&D team has been fully occupied with the electronics and software upgrade of our Serstech Arx product. The work is going according to plan, and we expect the project to be completed during the fourth quarter. After the upgrade, Serstech Arx will be built with only components that are readily available, which will allow us to scale up production as needed. So far in 2023, we have managed to deliver our products either on time or before the requested delivery date in all cases. Our delivery precision has been made possible thanks to the build-up of inventory and other preparations we did in 2022 and early 2023. With the soon finished electronics upgrade, we expect deliveries to go smoothly also in the coming year.

The outlook for the coming years remains positive, both due to our strong technical and sales capabilities and to the high demand in the market. As always, we will continue to see a large variation between individual quarters, but we remain confident in our longer-term growth target of 50% per year on average.

For further information, please contact:

Stefan Sandor,

CEO, Serstech AB Phone:

Email: 

or

Thomas Pileby,

Chairman of the Board, Serstech AB Phone:

Email:

or visit:

This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 08:47 CET on September 9, 2023.

Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).

About Serstech

Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.

Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at

Attachment



EN
09/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Serstech AB

 PRESS RELEASE

Serstech receives order of 5.6 MSEK from its US partner Proengin Inc

Serstech receives order of 5.6 MSEK from its US partner Proengin Inc Serstech has today received an order of 5.6 MSEK from its US partner Proengin Inc. The order consists of Serstech Arx instruments, the patented SERS kit, Serstech ChemDash software and substance libraries. This is the second order from the same end-customer within one year. The order will be delivered and invoiced in June 2024. For further information, please contact: Stefan Sandor,CEO, Serstech AB Phone: Email: orThomas Pileby,Chairman of the Board, Serstech AB Phone: Email: or visit: This is information that...

 PRESS RELEASE

Serstech Launches New Product – Serstech Arx mkII

Serstech Launches New Product – Serstech Arx mkII Serstech today announced its latest addition to its product portfolio – the Serstech Arx mkII. Shipments of the new product will start in May 2024. "With the new Serstech Arx mkII in hand, operators can identify many substances that were challenging for handheld devices in the past, including the new substance category biological toxins," says Serstech CEO Stefan Sandor. Serstech Arx mkII is launched with a companion mobile application, which enables law enforcement and first responders to access online resources and integrates...

 PRESS RELEASE

Serstech receives 1.9 MSEK order from US partner Field Forensics

Serstech receives 1.9 MSEK order from US partner Field Forensics Serstech has today received an order of approx. 1.9 MSEK from its US partner Field Forensics. The order consists of the newly launched Serstech Arx mkII, the patented SERS kit and ChemDash software. The order will be delivered and invoiced in Q2 2024.  For further information, please contact: Stefan Sandor, CEO, Serstech AB Phone: Email:  or Thomas Pileby, Chairman of the Board, Serstech AB Phone: Email:  or visit: This is information that Serstech AB (publ.) is obliged to make public pursuan...

 PRESS RELEASE

Kommuniké från ordinarie bolagsstämma i Serstech AB

Kommuniké från ordinarie bolagsstämma i Serstech AB Idag, den 29 april 2024, hölls ordinarie bolagsstämma i Serstech AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Besluten fattades med erforderlig majoritet. Stämman beslutade att fastställa resultat och balansräkning.Stämman beslutade i enlighet med styrelsens förslag att ingen utdelning skulle lämnas.Stämman beslutade att bevilja ansvarsfrihet för styrelseledamöter och verkställande direktör.Stämman beslutade vidare att styrelsen ska bestå av fem styrelseledamöter utan suppleanter. Val av ny styrelse St...

 PRESS RELEASE

First Quarter Report 2024

First Quarter Report 2024 Serstech Group - Key Figures Net sales amounted to KSEK 14 174 (12 337), an increase of 15%. EBITDA amounted to KSEK 1 368 (1 305), corresponding to an EBITDA margin of 10%. EBIT amounted to KSEK -522 (-1 642), corresponding to an EBIT margin of -4%. Cash flow from operating activities amounted to KSEK 1 627 (-1 570). Earnings per share amounted to SEK -0.00 (-0.01). Earnings per average number of shares amounted to SEK -0.00 (-0.01).  Message from the CEO The strong growth that resumed in 2023 continues into 2024, and by the end of the quarter, the total ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch